| parent | cefTAZidime | LP15242-8 |
| child | cefTAZidime [Susceptibility] | 18893-8 |
| child | cefTAZidime [Susceptibility] by Disk diffusion (KB) | 134-7 |
| child | cefTAZidime [Susceptibility] by Gradient strip | 6995-5 |
| child | cefTAZidime [Susceptibility] by Method for Slow-growing mycobacteria | 58705-5 |
| child | cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC) | 133-9 |
| child | cefTAZidime [Susceptibility] by Minimum lethal concentration (MLC) | 132-1 |
| child | cefTAZidime 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | 90850-9 |
| parent | cefTAZidime | LP15242-8 |
| child | cefTAZidime [Susceptibility] | 18893-8 |
| child | cefTAZidime [Susceptibility] by Disk diffusion (KB) | 134-7 |
| child | cefTAZidime [Susceptibility] by Gradient strip | 6995-5 |
| child | cefTAZidime [Susceptibility] by Method for Slow-growing mycobacteria | 58705-5 |
| child | cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC) | 133-9 |
| child | cefTAZidime [Susceptibility] by Minimum lethal concentration (MLC) | 132-1 |
| child | cefTAZidime 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | 90850-9 |
| PartDisplayName | en-US | cefTAZidime | Isolate | Antibiotic susceptibilities |
LOINC Version: 2.77
FHIR